Polyethylene Glycols: all 160 studies that test it
Page 2 of 2. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.
- Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of FunctionCompletedNCT02359825Phase 1
- Urotherapy vs. Urotherapy With Constipation Treatment for Nocturnal EnuresisWithdrawnNCT02337413Phase 4
- Urotherapy vs. Urotherapy With Constipation Treatment for Children With Lower Urinary Tract DysfunctionWithdrawnNCT02336906Phase 4
- Efficacy and Safety of Polyethylene Glycol 3350 (PEG 3350) for Relief of Constipation (MK-8114-005)WithdrawnNCT02292459Phase 3
- Safety of Total Daily Doses of Polyethylene Glycol (PEG) 400 Administered Orally to Healthy Male Human SubjectsCompletedNCT02260076Phase 1
- Efficacy and Safety of Prucalopride in Combination With Polyethylene Glycol or Lactulose in Women With Chronic ConstipationCompletedNCT02228616Phase 4
- Single Center Comparison of 4 FDA Approved, Commercially Available Bowel Purgatives for ColonoscopyWithdrawnNCT02124447Not applicable
- Colon Cleansing Quality of Polyethylene Glycol Compared With Polyethylene Glycol Plus Ascorbic Acid.CompletedNCT02073552Phase 4
- Patient Tolerability and Efficacy of Bowel Preparation With Split Dose Picosalax vs. Split Dose PEGTerminatedNCT02070341Phase 4
- Preparation Prior to Colonoscopy in ChildrenCompletedNCT02009202Not applicable
- A Phase I Study of 8-week Continuous Treatment With Polyethylene Glycol Loxenatide in Patients With Type 2 DiabetesCompletedNCT01976858Phase 1
- A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 DiabetesCompletedNCT01965496Phase 1
- Low-volume Polyethylene Glycol Bowel Preparation for ColonoscopyCompletedNCT01929590Phase 3
- Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)WithdrawnNCT01923376Not applicable
- Polyethylene Glycol for Childhood ConstipationCompletedNCT01875744Phase 4
- 2L Oral Bi-PegLyte Versus 2L Oral MoviPrep Regimen for Outpatient Colonic PreparationCompletedNCT01865916Phase 4
- Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy SubjectsCompletedNCT01834742Phase 1
- A Study to Compare the Effect of Transipeg 2.95 g or Forlax Junior 4 g in Children With ConstipationCompletedNCT01810653Phase 4
- A Randomized Prospective Trial Comparing Polyethylene Glycol and Sodium Picosulphate With Magnesium CitrateCompletedNCT01778192Phase 3
- Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening ColonoscopyCompletedNCT01714466Phase 2
- MiraLAX Versus Placebo to Prevent Constipation Following Urogynecologic SurgeryCompletedNCT01691742Not applicable
- Improving Bowel Preparation for the Colon CapsuleCompletedNCT01655095Phase 3
- Clostridial Infection and Oral Lavage -Improving Treatment Before Illness Becomes SevereStatus unknownNCT01630096Phase 4
- Single Dose Versus Split Dose Polyethylene Glycol-based Colonic Lavage for ColonoscopyCompletedNCT01610856Not applicable
- PEG Versus PEG+Bisacodyl Versus Sennosides for Colon Cleansing Before ColonoscopyCompletedNCT01531140Phase 4
- Short Course, Single-dose PEG 3350 for Colonoscopy Prep in ChildrenCompletedNCT01518790Not applicable
- Second Bowel Preparation for Colonoscopy FailureTerminatedNCT01510977Phase 4
- Incidence of Hyponatremia in PEG-SD Compared to PEG-ELSCompletedNCT01299779Not applicable
- Comparator Study of PEG 3350 Versus Prucalopride in Females With Chronic ConstipationCompletedNCT01251822Phase 3
- Assessment of Combined Bowel Preparation for Capsule Endoscopy StudyCompletedNCT01243736Phase 1
- Efficacy, Safety and Tolerability of Split-dose of PEG Compared With NaP Solution for Colonoscopy Preparation: A Randomized, Controlled TrialCompletedNCT01229800Phase 3
- Does 3 Months Therapy With Vitamin D + Peg + Ribavirin Improve Sustained Virologic Response (SVR) in Genotype 2, 3 Chronic Hepatitis C Patients?Status unknownNCT01151397Not applicable
- Does Vitamin D Improves Sustained Virologic Response (SVR) in Genotype 2,3 Chronic Hepatitis C Patients?Status unknownNCT01146626Not applicable
- Same-day, Reduced Volume Bowel PreparationWithdrawnNCT01044394Phase 2
- A Study Comparing PEG-3350 (Miralax) and Gatorade With PEG-ELS (Golytely) for Bowel Preparation Prior to ColonoscopyStatus unknownNCT01028573Not applicable
- A Trial Comparing Bowel Preparation and Patient Tolerability of Miralax Versus GolytelyStatus unknownNCT00889655Phase 4
- Effects of Oral PEG 3350 on Electrolyte BalanceCompletedNCT00868985Phase 1
- Randomized, Double-Blinded, Placebo-Controlled Trial of Laxatives for Children With Urge SyndromeCompletedNCT00765557Early Phase 1
- Probiotics for Eradication of Carbapenem Resistant Klebsiella PneumoniaStatus unknownNCT00722410Phase 1/2
- Small Bowel Cleansing Prior to Video Capsule Endoscopy ExaminationCompletedNCT00677794Phase 4
- Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of VisionCompletedNCT00627302Phase 4
- Comparison of Two Methods of Administration of a PEG SolutionCompletedNCT00626054Phase 4
- Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual QualityCompletedNCT00622037Phase 4
- Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).CompletedNCT00620893Phase 4
- Comparison of PEG Solutions With and Without Electrolytes in the Treatment of ConstipationCompletedNCT00603681Phase 4
- A Pilot Study of a New PEG3350 Dose Formulation For Use in Constipated ChildrenCompletedNCT00583609Phase 4
- Polyethylene Glycol Versus Sodium Phosphate for Colon Preparation After Failure of First Preparation for ColonoscopyTerminatedNCT00558376Not applicable
- PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to ColonoscopyCompletedNCT00390598Phase 2/3
- A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated ChildrenCompletedNCT00319670Phase 4
- Study of Long-term Use of Forlax® in Elderly Patients With Chronic ConstipationCompletedNCT00276354Phase 4
- To Determine the Effect of Forlax® Treatment in Children With Chronic Constipation Who May Also Suffer From Soiling/ Faecal Incontinence.CompletedNCT00255372Phase 3
- Preference of Tegaserod vs. PEG 3350 in Patients With ConstipationCompletedNCT00171522Phase 4
- Evaluation Of The Efficacy Of HalfLYTELY For Bowel Cleansing Before Virtual Colonoscopy and Conventional Colonoscopy.CompletedNCT00164177Phase 4
- HalfLytely Bowel Prep System for ColonoscopyCompletedNCT00164164Phase 3
- A Comparison of the Efficacy and Safety of HalfLytely Vs Visicol Prior To Colonoscopy.CompletedNCT00164151Phase 3
- An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated PatientsCompletedNCT00164125Phase 4
- Extended Use of Polyethyleneglycol3350 Laxative in Constipated PatientsCompletedNCT00153153Phase 4
- Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic ConstipationCompletedNCT00153140Phase 4
- Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating MedicationsCompletedNCT00153127Phase 4
- PolyethyleneGlycol3350 Laxative vs Placebo in Constipated ChildrenCompletedNCT00153114Phase 4